IDO1 and neoplasm: This is intriguing, because IDO1 catalyzes the conversion of Trp to Kyn, which can suppress T-cell activity and allow tumor cells to escape clearance by the immune system [9], particularly through Kyn-mediated aryl hydrocarbon receptor (AHR) activation [10].